SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-181088
Filing Date
2020-06-26
Accepted
2020-06-26 17:01:08
Documents
15
Period of Report
2020-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d920857d8k.htm   iXBRL 8-K 89023
2 EX-4.1 d920857dex41.htm EX-4.1 905209
3 EX-4.8 d920857dex48.htm EX-4.8 106289
4 EX-4.9 d920857dex49.htm EX-4.9 754694
  Complete submission text file 0001193125-20-181088.txt   2343925

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20200622.xsd EX-101.SCH 2745
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20200622_lab.xml EX-101.LAB 15302
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20200622_pre.xml EX-101.PRE 9645
14 EXTRACTED XBRL INSTANCE DOCUMENT d920857d8k_htm.xml XML 3139
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56114 | Film No.: 20994861
SIC: 2834 Pharmaceutical Preparations